Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
- PMID: 26659802
- DOI: 10.1007/7651_2015_296
Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay
Abstract
Two fundamental aspects for precisely predicting the risk of developing type 1 diabetes by islet autoantibodies are assay sensitivity and disease specificity. We have recently developed electrochemiluminescent (ECL) insulin autoantibody (IAA) and GAD65 autoantibody (GADA) assays. ECL assays are sensitive, able to identify the initiation of islet autoimmunity earlier in life among high-risk young children before clinical onset of diabetes and are more disease specific because they are able to discriminate high-affinity, high-risk diabetes specific islet autoantibodies from low-affinity, low-risk autoantibodies.
Keywords: Assay; Autoantibodies; Diabetes; Prediction.
Similar articles
-
Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.Diabetes Metab J. 2020 Apr;44(2):260-266. doi: 10.4093/dmj.2019.0007. Epub 2019 Nov 12. Diabetes Metab J. 2020. PMID: 31769235 Free PMC article.
-
Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.Diabetes Care. 2013 Aug;36(8):2266-70. doi: 10.2337/dc12-2245. Epub 2013 Feb 19. Diabetes Care. 2013. PMID: 23423694 Free PMC article.
-
Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.Diabetes Technol Ther. 2015 Feb;17(2):119-27. doi: 10.1089/dia.2014.0186. Epub 2015 Jan 6. Diabetes Technol Ther. 2015. PMID: 25562486 Free PMC article.
-
Type 1 diabetes islet autoantibody markers.Diabetes Technol Ther. 2002;4(6):817-39. doi: 10.1089/152091502321118838. Diabetes Technol Ther. 2002. PMID: 12614488 Review.
-
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):395-415. doi: 10.1002/dmrr.554. Diabetes Metab Res Rev. 2005. PMID: 15895384 Review.
Cited by
-
Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy.Front Endocrinol (Lausanne). 2022 Aug 5;13:959011. doi: 10.3389/fendo.2022.959011. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992113 Free PMC article. Review.
-
Prevalence of antibodies targeting ubiquitin-conjugating enzyme 2L3 and eukaryote translation elongation factor 1 α1 in Chinese Han and American Caucasian populations with type 1 diabetes.Endocr Connect. 2022 Nov 23;11(12):e220325. doi: 10.1530/EC-22-0325. Print 2022 Dec 1. Endocr Connect. 2022. PMID: 36279111 Free PMC article.
-
Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay.J Clin Cell Immunol. 2017;8(6):1000531. doi: 10.4172/2155-9899.1000531. Epub 2017 Dec 11. J Clin Cell Immunol. 2017. PMID: 29487479 Free PMC article. No abstract available.
-
Large-Scale Screening in General Population Children for Celiac Disease with a Multiplex Electrochemiluminescence (ECL) Assay.J Immunol Res. 2020 Dec 24;2020:8897656. doi: 10.1155/2020/8897656. eCollection 2020. J Immunol Res. 2020. PMID: 33426098 Free PMC article.
-
Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.Diabetes Metab J. 2020 Apr;44(2):260-266. doi: 10.4093/dmj.2019.0007. Epub 2019 Nov 12. Diabetes Metab J. 2020. PMID: 31769235 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical